Literature DB >> 21837927

Added value of pharmacist-acquired drug histories in an orthopaedic ward.

S Quennery1, O Cornu, B Sneyers, J C Yombi.   

Abstract

In Belgian hospitals, drug histories of patients taken on admission are generally collected by medical trainees, physicians and nurses. As errors in drug histories may lead to medication errors and adverse drug events, we aimed at comparing the data obtained by a clinical pharmacist with those obtained by the nurses in a surgical orthopaedic ward. In this four months study, 50 patients, with a mean age of 66 years, were included. Out of these 50 drug histories, 107 differences were found when comparing the data gathered by the nurses with the data of the pharmacist. On average, there were 2.1 discrepancies per patient. Omission of a drug and incorrect or unknown dose accounted for 80.3% of the discrepancies, while allergy and/or intolerance, incorrect frequency and addition of a drug accounted for respectively 11.2%, 4.8% and 3.7%. Interestingly, six drug categories represented almost 55% of the drug-related discrepancies.These were, in order of importance: anxiolytic and neuroleptics, antacids and proton pump inhibitors (PPI's), painkillers, antidepressants, aspirin and eye drops. Finally, 27% of the discrepancies concerned "over the counter" drugs. From this study we were able to conclude that the clinical pharmacist performed more complete and more accurate drug histories than nurses in the surgical orthopaedic care unit, especially in patients taking multiple drugs. These results suggest that drug histories taken by a pharmacist may lead to a reduction of potential adverse drug events during hospitalisation.

Entities:  

Mesh:

Year:  2011        PMID: 21837927     DOI: 10.2143/ACB.66.3.2062546

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  4 in total

1.  Medication reconciliation of patients with hip fracture by clinical pharmacists.

Authors:  Anne Marie Gjerde; Elizabeth Aa; Janne Kutschera Sund; Pal Stenumgard; Lars Gunnar Johnsen
Journal:  Eur J Hosp Pharm       Date:  2015-11-02

2.  Impact of pharmacy-supported interventions on proportion of patients receiving non-indicated acid suppressive therapy upon discharge: A systematic review and meta-analysis.

Authors:  Devada Singh-Franco; David R Mastropietro; Miriam Metzner; Michael D Dressler; Amneh Fares; Melinda Johnson; Daisy De La Rosa; William R Wolowich
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

3.  Potential role of a pharmacist to enhance medication-related aspects of clinical trials conducted in a dedicated clinical research unit.

Authors:  Kimberly A Redic; Amy Skyles; John Zaccardelli
Journal:  Contemp Clin Trials Commun       Date:  2017-03-18

4.  Impact of a preoperative pharmaceutical consultation in scheduled orthopedic surgery on admission: a prospective observational study.

Authors:  Amélie Renaudin; Géraldine Leguelinel-Blache; Chloé Choukroun; Audrey Lefauconnier; Christophe Boisson; Jean-Marie Kinowski; Philippe Cuvillon; Hélène Richard
Journal:  BMC Health Serv Res       Date:  2020-08-13       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.